IMR Press / CEOG / Volume 40 / Issue 2 / pii/1630388197704-521110099

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report
Cesarean section scar pregnancy treatment - case report
Show Less
1 “Narodni Front” University of Belgrade, School of Medicine, Clinic of Gynecology and Obstetrics, Belgrade (Serbia)
Clin. Exp. Obstet. Gynecol. 2013, 40(2), 304–306;
Published: 10 June 2013
Abstract

This is a case report of a 36-year-old patient with an ectopic pregnancy located in the previous cesarean section scar following in vitro fertilization (IVF). The patient was treated by 50 mg of intrasacular methotrexate locally under ultrasound guidance. Transvaginal ultrasound (TVUS) confirmed that the pregnancy was no longer vital within 24 hours, dilatation and aspiration of the ovular tissue were performed after seven days and it was sent for pathohistological analysis. Eight hours after the procedure, the patient began bleeding abundantly and was consequently treated locally by 1 ml of Beriplast® P Combi set, human fibrinogen, and human thrombin set (CSL Behring). After the treatment, the patient was discharged in good health, with normal laboratory values. Her menstrual period resumed 35 days after the procedure.
Keywords
Ectopic pregnancy
Cesarean section scar
Methotrexate
Share
Back to top